A single center, inter-observer evaluation of vestibular schwannoma stereotactic radiosurgery and its dosimetric impact
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Perez-Calatayud, Maria Jose
- Menendez, Antonio
- Conde, Antonio
- Celada, Francisco
Grupos
Abstract
The aim of this work was to evaluate the inter- and intra-observer variation in contouring vestibular schwannoma (VS) and the organs-at-risk (OAR), and its dosimetric impact in Volumetric Modulated Arc Therapy (VMAT). Three VS typical cases were contoured by four clinicians. The Agreement Volume Index (AVI) appeared to be notably higher in VS than in OARs, such that the dose coverage of VS is fairly robust. In OARs, the largest variation was +1.02Gy in dmax for the brainstem, +0.78Gy in dmean for the cochlea and +1.05Gy in dmax of the trigeminal nerve. Accordingly, it was decided that all VS delineations for stereotactic radiosurgery (SRS), and all frame-based SRS contouring in general, should always be reviewed by a second physician. In addition, the retrospective presentation of VS cases at daily peer review meetings has also been adopted to ensure that the consensus is constantly updated, as well as for training purposes.
Filiaciones
Filiaciones no disponibles
Keywords
- SRS; schwannoma; inter-observer; VMAT
Proyectos asociados
BIOMARCADORES DINÁMICOS BASADOS EN FIRMAS TISULARES MULTIPARAMÉTRICAS PARA EL SEGUIMIENTO Y EVALUACIÓN DE LA RESPUESTA A TRATAMIENTO DE PACIENTES CON GLIOBLASTOMA Y CANCER DE PRÓSTATA.
Investigador Principal: JUAN MIGUEL GARCÍA GÓMEZ
2016_0704_CPC_GARCIA_GOMEZ . 2016
PerProGlio. Integrative Personal Omics Profiles in Glioblastoma Recurrence and Therapy Resistance.
Investigador Principal: LUIS MARTÍ BONMATÍ
AC18/00077 . COMISION EUROPEA . 2019
CHAIMELEON. ACCELERATING THE LAB TO MARKET TRANSITION OF AI TOOLS FOR CANCER MANAGEMENT.
Investigador Principal: LUIS MARTÍ BONMATÍ
952172 . COMISION EUROPEA . 2020
ESTUDIO OBSERVACIONAL RETROSPECTIVO SOBRE LA EFECTIVIDAD DE GLIOLAN® EN EL TRATAMIENTO DE LOS GLIOMAS MALIGNOS EN ESPAÑA (ESTUDIO VISIONA).
Investigador Principal: CARLOS BOTELLA ASUNCION
GEB-ACA-2011-01
TRATAMIENTO RADIOTERÁPICO EN PACIENTES CON CÁNCER DE PRÓSTATA EN FUNCIÓN DEL NIVEL DE RIESGO CONFORME A LA PRÁCTICA CLÍNICA HABITUAL EN LOS SERVICIOS DE ONCOLOGÍA RADIOTERÁPICA ESPAÑOLES.
Investigador Principal: ERICA COLLADO BALLESTEROS
GIC-RAD-2013-01
ESTUDIO DE BRAQUITERAPIA ELECTRÓNICA PARA CARCINOMA CUTÁNEO BASOCELULAR.
Investigador Principal: JOSÉ PÉREZ CALATAYUD
BCCBRACHY
EVALUACIÓN DEL USO DE RECURSOS Y COSTES CON O-ARM EN CIRUGÍAS DE ESTIMULACIÓN CEREBRAL PROFUNDA Y CIRUGÍAS DE ESPALDA COMPLEJAS.
Investigador Principal: CARLOS BOTELLA ASUNCION
ECOPRES
OPTIMIZING IRRADIATION THROUGH MOLECULAR ASSESSMENT OF LYMPH NODE (OPTIMAL).
Investigador Principal: FRANCISCO JOSÉ MARTÍNEZ ARCELUS
GIC-RAD-2014-02 . 2015
A RANDOMIZED, DOUBLÉ-BLIND, PLACEBO-CONTROLLE ADJUVANT TRIAL IN NEWLY DIAGNOSED PRIMARY GLIOBLASTOMA SUBJECTS TO ASSESS THE EFFICACY AND SAFETY OF 2-HYDROXYLEIC ACID (2-OHOA) IN COMBINATION WITH RADIOTHERAPY AND TEMOZOLMIDE STANDARD OF CARE TREATMENT.
Investigador Principal: REGINA GIRONÉS SARRIÓ
MIN-003-1806 . 2019
Estudio Fase 1b, abierto, de búsqueda de dosis de CC-90010 en combinación con temozolomida con o sin radioterapia en sujetos con glioblastoma de nuevo diagnóstico.
Investigador Principal: REGINA GIRONÉS SARRIÓ
CC-90010-GBM-002 . 2022
MATTO-GBM FCAECC-Multimodality Artificial intelligence open-source Tools for Radiation Treatment Optimization in patients with Glioblastoma.
Investigador Principal: LUIS MARTÍ BONMATÍ
TRANSCAN-3 JTC2022 . COMISION EUROPEA . 2023
Análisis de biomarcadores de efecto abscopal en pacientes tratados con radio-inmunoterapia.
Investigador Principal: RODOLFO CHICAS SET
2023-1061-1 . 2024
DeTeRMIA .Desarrollo de Técnicas Avanzadas de RM para el Diagnóstico Rápido del Cáncer de Próstata.
Investigador Principal: LEONOR CERDÁ ALBERICH
PMPTA23/00010 . INSTITUTO DE SALUD CARLOS III . 2024
Cita
Perez MJ,Menendez A,Lliso F,Carmona V,Conde A,Celada F,Bernisz M,Botella C,Perez J. A single center, inter-observer evaluation of vestibular schwannoma stereotactic radiosurgery and its dosimetric impact. Journal of Radiosurgery and SBRT. 2024. 9. (2):p. 113-120.